Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001209191-23-057387

Options or other derivatives

  • General Counsel & Corp Sec acquired 46,284 shares (grant or award)
  • General Counsel & Corp Sec returned 186,100 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Allan Jonathan General Counsel & Corp Sec 2023-12-01 Returned to the company · Employee Stock Option (Right to Buy) −65,000 0 D
Allan Jonathan General Counsel & Corp Sec 2023-12-01 Returned to the company · Employee Stock Option (Right to Buy) −121,100 0 D
Allan Jonathan General Counsel & Corp Sec 2023-12-01 Grant or award · Restricted Stock Unit (RSU) +46,284 46,284 D
Loading xslF345X05/doc4.xml…